Smithbridge Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Smithbridge Asset Management's ELV Position: Q2 2026 in Review
Smithbridge Asset Management reduced its Elevance Health (ELV) stake by 4.9% in Q2 2026, selling an estimated $20.4K and leaving 1,070 shares worth $414K. The position accounts for 0.06% of the portfolio, ranked #137.
Smithbridge Asset Management first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.47M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Smithbridge Asset Management held 1,070 shares of Elevance Health worth $414K as of Q2 2026.
- Smithbridge Asset Management sold 55 Elevance Health shares in Q2 2026, an estimated $20.4K.
- Elevance Health made up 0.06% of Smithbridge Asset Management's portfolio in Q2 2026, its #137 holding.
- Smithbridge Asset Management first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
- Smithbridge Asset Management's Elevance Health position peaked at $1.47M in Q3 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.